SLNO- Soleno Therapeutics, Inc.

Name: Soleno Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Soleno Therapeutics, Inc. (SLNO) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. SLNO is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Anish Bhatnagar	569.5K	$30.19M	-
CFO	MacKaness James H	103.2K	$5.47M	-
Other	Joshi Manher	72.3K	$3.83M	-
Other	Manning Meredith	67.2K	$3.56M	-
Other	Norrett Kevin	64.3K	$3.41M	-

Activity

Buys and sells only

Transactions

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 1, 2024	Yen Kristen	See Remarks	Sell	2,170	$41.54	$90,136.17	-4.7%	+19.4%	+95.4%
Jul 1, 2024	MacKaness James H	Chief Financial Officer	Sell	7,190	$41.54	$298,653.62	-5.8%	+19.4%	+95.4%
Jul 1, 2024	Hirano Patricia C	See Remarks	Sell	2,170	$41.54	$90,136.17	-2.1%	+19.4%	+95.4%
Jul 1, 2024	Anish Bhatnagar	Chief Executive Officer	Sell	19,256	$41.54	$799,843.97	-6.4%	+19.4%	+95.4%
Apr 30, 2024	Vivo Opportunity, LLC67	10% Owner	Sell	1,101,242	$46.95	$51,701,551.46	-6.8%	+4.8%	+67.6%
Apr 1, 2024	Yen Kristen	See Remarks	Sell	2,218	$41.34	$91,693.58	-4.4%	+1.9%	+64.5%
Apr 1, 2024	MacKaness James H	Chief Financial Officer	Sell	5,175	$41.34	$213,937.42	-3.9%	+1.9%	+64.5%
Apr 1, 2024	Hirano Patricia C	See Remarks	Sell	2,218	$41.34	$91,693.58	-2.3%	+1.9%	+64.5%
Apr 1, 2024	Anish Bhatnagar	Chief Executive Officer	Sell	18,980	$41.34	$784,644.65	-5.7%	+1.9%	+64.5%
Jan 25, 2024	Anish Bhatnagar	Chief Executive Officer	Sell	2,527	$48.30	$122,054.10	-1.4%	-16.0%	+2.6%

← PrevPage 4Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC